Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates

Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates

Purpose: To analyze prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates from patients with possible MDR TB of Puducherry, South India and to explore the association of specific mutations conferring rifampicin (RIF) resi...

Full description

Bibliographic Details
Main Authors:	Muthuraj Muthaiah, Smita Sunil Shivekar, Vidya Raj Cuppusamy Kapalamurthy, Chitra Alagappan, Anbazhagi Sakkaravarthy, Usharani Brammachary
Format:	Article
Language:	English
Published:	Elsevier 2017-08-01
Series:	Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405579417300244

Similar Items

Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes
by: C.K. Vidyaraj, et al.
Published: (2019-04-01)

Assess the Diagnostic Accuracy of GeneXpert to Detect <i>Mycobacterium tuberculosis</i> and Rifampicin-Resistant Tuberculosis among Presumptive Tuberculosis and Presumptive Drug Resistant Tuberculosis Patients
by: Venkateswari Ramachandra, et al.
Published: (2023-12-01)

Isoniazid resistance profile in rifampicin resistant Mycobacterium tuberculosis
by: Naomee Shareef, et al.
Published: (2023-09-01)

MUTATIONS OF MYCOBACTERIUM TUBERCULOSIS CAUSING RESISTANCE TO RIFAMPICIN AND ISONIAZID IN THE PATIENTS WITH DIFFERENT HIV STATUS
by: E. I. Veselova, et al.
Published: (2019-02-01)

Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
by: Edgar Kigozi, et al.
Published: (2018-01-01)

Isoniazid and Rifampicin Resistance-Conferring Mutations in <i>Mycobacterium tuberculosis</i> Isolates from South Africa
by: Afsatou Ndama Traoré, et al.
Published: (2023-08-01)

Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis
by: Mosayeb Rostamian, et al.
Published: (2023-08-01)

Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01)

Risk Factors and Treatment Outcome Analysis Associated with Second-Line Drug-Resistant Tuberculosis
by: Muralidhar Aaina, et al.
Published: (2021-12-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among <it>Mycobacterium tuberculosis </it>isolates from Ethiopia
by: Tessema Belay, et al.
Published: (2012-02-01)

Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis
by: Soniya Sharma, et al.
Published: (2014-01-01)

Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India
by: Ravibalan Thirumurugan, et al.
Published: (2015-11-01)

Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
by: Gadissa Bedada Hundie, et al.
Published: (2016-01-01)

Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia
by: Amir Alelign, et al.
Published: (2019-04-01)

High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
by: Naima Fasih, et al.
Published: (2012-01-01)

Blood agar validation for susceptibility testing of isoniazid, rifampicin, ethambutol, and streptomycin to Mycobacterium tuberculosis isolates.
by: Ahmet Yilmaz Coban
Published: (2013-01-01)

Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
by: Jainagul Isakova, et al.
Published: (2018-03-01)

Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis
by: Zhenzhen Wang, et al.
Published: (2022-10-01)

Correction: Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
by: Gadissa Bedada Hundie, et al.
Published: (2017-01-01)

Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
by: El mashad Noha, et al.
Published: (2009-01-01)

Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
by: El mashad Noha, et al.
Published: (2009-02-01)

Resazurin microtiter assay for isoniazid, rifampicin, ethambutol and streptomycin resistance detection in Mycobacterium tuberculosis: Updated metaanalysis
by: Ahmet Yilmaz Coban, et al.
Published: (2014-01-01)

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to isoniazid, rifampicin (MTBDR plus), fluoroquinolone and injectable second-line drugs (MTBDRsl)
by: Hasmik Margaryan
Published: (2015-01-01)

Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis
by: Melese Abate Reta, et al.
Published: (2021-09-01)

Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB® Kit for the diagnosis of tuberculosis.
by: Francesco Bisognin, et al.
Published: (2020-01-01)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
by: Aruldhas, B, et al.
Published: (2018)

Rifampicin tolerance and growth fitness among isoniazid-resistant clinical Mycobacterium tuberculosis isolates: an in-vitro longitudinal study.
by: Vijay, S, et al.
Published: (2023)

Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia*
by: Zufan Bedewi Omer, et al.
Published: (2016-01-01)

Molecular Analysis of Rifampicin Resistance Conferring Mutations in Mycobacterium tuberculosis
by: Tawgozy et al.
Published: (2020-05-01)

Molecular Characterization of Rifampicin Associated Mutation in Mycobacterium tuberculosis Isolates
by: Ali Tahir, et al.
Published: (2021-06-01)

Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
by: Lijie Zhang, et al.
Published: (2024-01-01)

Discordance between genotypic and phenotypic methods for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis and the correlation with patient treatment outcomes
by: Zegeye Bonsa, et al.
Published: (2024-02-01)

The Genotype MTBDRplus ver. 2.0 test as a quick indicator of resistance to rifampicin and isoniazid in Mycobacterium tuberculosis strains
by: Salvatore Nisticò, et al.
Published: (2013-08-01)

Evaluation of genotype MTBDRplus assay for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis clinical isolates from Pakistan
by: Hasnain Javed, et al.
Published: (2016-01-01)

Rifampicin tolerance and growth fitness among isoniazid-resistant clinical Mycobacterium tuberculosis isolates from a longitudinal study
by: Vijay, S, et al.
Published: (2024)

Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains
by: Diana Machado, et al.
Published: (2018-03-01)

In silico analyses of isoniazid and streptomycin resistance-associated mutations in Mycobacterium tuberculosis
by: Rushikesh Singh Dasoondi, et al.
Published: (2023-01-01)

Isoniazid, The Frontline of Resistance in Mycobacterium tuberculosis
by: James B. Whitney, et al.
Published: (2002-12-01)

Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda
by: Isabel Cuella-Martin, et al.
Published: (2023-01-01)